There is a number of reports suggesting that soluble endoglin may be regarded as a biomarker of endothelial dysfunction, for example in pre-eclampsia [3], atherosclerosis [6,7], hypercholesterolemia [8], diabetes mellitus and hypertension [9] and chronic coronary artery disease [10]. Here, ENG is linked to endothelial dysfunction.